Skip to main content
Caplight Logo









Genics

Genics

Private
BrisbaneHealthcare & Life Scienceshttps://genics.com.au

Last Round

Grant

Mar 28, 2019

Company Overview

Genics operates in Healthcare & Life Sciences and is based in Brisbane. Its latest recorded funding round was a Grant round in March 2019.

Genics is a biotechnology company that provides pathogen detection and genomic breeding services for the aquaculture and agriculture industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Genics Comparables

Compare Genics with similar companies based on industry and business-model similarity.

Genics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Forte Biotech
82%
Biomed AgriTech
80%
Kennebec River Biosciences
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Genics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 28, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Melony Sellars

Chief Executive Officer & Managing Director

Executive Team

For institutional investors. Book with your work email.

Genics Investors

Notable investors and investment history

Genics investors
InvestorRounds
Australian GovernmentGrant
Entrepreneurs' ProgrammeGrant
Main Sequence VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 14, 2025

    Grew 15% QoQ, from 39 to 45 employees.

  • May 3, 2025

    Monthly visitors increased 84% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Genics Filings

Explore SEC and related filing metadata, where available.

Genics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Genics's valuation, stock price, and market status.

Is Genics a public or private company?

Genics is a private company.

What is the current stock price of Genics?

Genics is a private company, so its shares have no public market price. Caplight tracks Genics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genics worth (valuation)?

Valuation information for Genics is not publicly available.

Can I buy Genics stock?

Genics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genics's last funding round?

Genics's most recent funding round was Grant on March 28, 2019.

Who are the main investors in Genics?

Key investors in Genics include Australian Government, Main Sequence Ventures.

Will Genics IPO soon?

No public IPO plans have been announced for Genics.

How can I track Genics secondary market activity?

Caplight tracks bids, offers, and trades in Genics's shares on secondary markets.

Firmographic Details

HeadquartersBrisbane
Employee Range30
Year Founded2018
Last FundingMar 28, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?